Core Points - The 8th China International Import Expo took place from November 5 to 10, showcasing a commitment to international trade and cooperation [1][3] - Changsha sent over 800 professional attendees to the expo, emphasizing its dedication to open innovation and global resource integration [3][16] - Notable companies like Metro, Fosun Pharma, and Volkswagen participated, highlighting their long-term engagement with the expo and Changsha's high-level opening policies [3][5] Group 1: Participation and Engagement - Changsha has consistently participated in the expo for eight years, demonstrating a strong commitment to procurement, project negotiations, and cultural exchanges [3][5] - Metro showcased 130 globally selected products, which are available in its stores nationwide, illustrating the direct impact of the expo on local consumers [3][5] - Fosun Pharma introduced a new particle therapy system, showcasing innovation in cancer treatment technology [3][10] Group 2: Innovation and Technology - Changsha's representation at the expo highlighted its technological advancements, with companies like SANY showcasing leading products in the construction machinery sector [7][10] - The introduction of new products, such as the AI-powered hearing aid by Kefu Medical, reflects the city's focus on cutting-edge innovation [10][12] - The collaboration between Toyota and Minmetals on a new energy storage system demonstrates the integration of international capital and technology [10][12] Group 3: Cultural and Economic Development - The expo served as a platform for showcasing traditional and modern cultural elements from Changsha, including local handicrafts and traditional medicine [12][14] - Changsha's new tea brand, Ningji, is expanding internationally, indicating the city's growing influence in the global beverage market [14][16] - The signing of 12 key projects during the expo highlights Changsha's strategic focus on smart manufacturing, cross-border trade, and AI capabilities [16][18] Group 4: Open Economy and Trade Growth - Changsha's import and export volume is projected to grow at an average rate of 4.3% from 2021 to 2024, with significant increases in trade with Africa [18] - The city has attracted nearly three-quarters of the province's actual foreign investment, showcasing its strong economic environment [18] - The establishment of various promotional and matchmaking events during the expo aims to enhance cooperation and attract high-quality goods and services to Changsha [16][18]

11月6日，由上海证券交易所、中证中小投资者服务中心、上海证券同业公会指导，国泰海通证券投资者教育基地、国泰海通证券上海分公司主办，复星医 药（600196）、全景投资者教育上海基地共同协办的"我是股东"国泰海通证券走进上市公司——复星医药在进博会展览馆举行。 进博会作为全球瞩目的合作交流平台，复星医药连续八届全勤参展，彰显了其对创新与开放合作的高度重视。会中，复星医药董事长陈玉卿在致辞中表示， 进博会不仅是创新产品的展示窗口，更是产业升级的重要平台。依托进博会，复星医药实现了从"展品变商品、展商变投资商"的转化，推动了多款前沿技术 和创新药械产品加速落地中国，同时也将中国市场的创新成果反哺全球市场。 陈玉卿特别提到了复星医药在肿瘤治疗领域的创新突破。奕凯达自2021年上市成为中国首款CAR-T细胞治疗产品以来，已成功治疗超1000位淋巴瘤患 者。"第二款产品也已申报上市材料，预计在可预期的时间内将为血液瘤患者群体带来新的治疗选择。"陈玉卿表示。 在展台参观环节，复星医药带来了众多最新、备受瞩目的产品，其中不少是"首展"产品。如Marie立式粒子治疗室内系统，其小巧的设计使得在30平米的空 间内就能集聚多种粒 ...

新华社上海11月9日电 题：从一家企业展台看全球创新与本土创新的双向奔赴 新华社记者杨有宗、杜康 复星医药董事长陈玉卿表示："未来我们将积极推动这一创新技术在中国的落地，希望为中国肿瘤患者 带来更舒适、更高效的治疗选择。" 一年一度的进博会不仅是一场"引进来"的全球贸易盛会，也是全球创新与本土创新双向奔赴的舞台。 连续八年在复星医药展台展出的中国首款CAR-T产品奕凯达，用一组数据诠释了创新本土化对全球的反 哺力：累计治疗超1000位淋巴瘤患者、覆盖29个省区市190多家治疗中心、纳入超190款医保与商保…… 这些本土实践，正成为复星医药与海外合作伙伴共同提升CAR-T产品可及性的重要依据。 达芬奇手术机器人的"进化史"更是双向奔赴的缩影。连续八年参展的达芬奇手术机器人，从最初的"设 备引进"，到如今构建"手术机器人生态圈"的转型，助力我国手术机器人行业迈向高质量发展新阶段。 自达芬奇手术机器人进入中国以来，已累计培训1.5万余名医疗专业人士，这些本土医生的操作经验与 临床方案正通过全球协作网络，反哺达芬奇机器人的全球技术升级。直观复星首席执行官刘釜均表 示："直观复星正在加速构建以中国医患需求为核心，融合本 ...

从2018年到2025年，中国国际进口博览会走过八载光阴。这8年，170家海外企业和27家机构从未缺席， 成为8届进博会的"全勤生"。其中，不少"老朋友"参展规模逐年扩大，展出形式持续创新。进博会见证 着参展企业深耕中国大市场取得的丰硕成果。 位于农食产品展区的乐斯福也是进博会"全勤生"。8年来，乐斯福在中国的投资和业务表现均有显著增 长，更借助进博会强大的平台效应实现了跨越式发展。"仅第七届进博会前3天，我们就举行了17场集中 签约仪式，达成了涵盖市场、研发、产品等多个层面的合作。"乐斯福相关负责人介绍，今年，企业带 来了多款针对中国市场研发的新品。 从2018年的36平方米小展位，到2025年的180平方米大展台，聊起连续8年参展的经历，德国水处理品牌 汉斯希尔中国公司相关负责人唐鹏说："通过进博会提供的广阔平台，企业不仅实现了展品变商品，还 实现了从民用到商用的突破。" 促创新，增强投资信心 进博会持续激活创新动能，让中国大市场真正成为全球创新的试验场、利润场、应用场，进一步坚定跨 国企业扎根中国的信心。 艾默生在中国建立了15个制造运营基地、8个研发创新中心、2个系统工程中心。"我们在中国研发的产 品 ...

Core Insights - The China International Import Expo (CIIE) has seen consistent participation from 170 overseas companies and 27 institutions over its eight-year history, showcasing the growing commitment of international firms to the Chinese market [1] - The expo serves as a platform for companies to transform exhibits into products, enhancing their market presence and fostering innovation [2][3] - CIIE is recognized as a bridge for global businesses to enter the Chinese market while also facilitating the export of Chinese goods [4][5] Group 1: Company Participation and Growth - Amorepacific showcased nearly 300 products, including over 20 new launches exclusive to China, indicating a strong commitment to the Chinese market [2] - Lesaffre has experienced significant growth in investment and business performance in China, leveraging the expo for collaborative agreements across various sectors [2] - Emerson has established 15 manufacturing bases and 8 R&D centers in China, emphasizing local product development that supports both domestic and global markets [3] Group 2: Innovation and Development - The CIIE has activated innovation, positioning China as a global testing ground for new ideas and applications, thereby boosting multinational companies' confidence in the market [2][3] - Toyota and Pony.ai introduced a mass-production version of their autonomous vehicle at the expo, highlighting the collaboration between foreign brands and local innovation [3] - Volkswagen continues to deepen its investment in local R&D, collaborating with domestic partners to enhance technological capabilities [3] Group 3: Market Opportunities and Global Sharing - CIIE is described as a global public good that shares development opportunities, aiding foreign companies in entering the Chinese market while promoting Chinese exports [4][5] - L'Oréal's participation reflects a strong belief in the Chinese market, with plans for future involvement in upcoming expos [4] - Charoen Pokphand Group introduced 231 products at the expo, including new offerings from Thailand, showcasing its role in enriching consumer choices in China [5]

Core Insights - The 8th China International Import Expo (CIIE) opened in Shanghai on November 5, showcasing innovations in the medical device and pharmaceutical sectors under the theme "Healthy China, Beautiful Life" [1] - The medical device and pharmaceutical health exhibition area, known for its high competition, featured global leaders in medical technology and pharmaceuticals, including the top ten medical device companies and 11 Fortune 500 pharmaceutical firms [1] Company Highlights - **Roche**: Displayed over 40 products, including new treatments for Alzheimer's, Parkinson's, and lupus nephritis, with the anti-CD20 monoclonal antibody, Gazyva, and the Port Delivery System (PDS) for eye diseases being key highlights [2][4][5] - **Siemens**: Focused on high-incidence cancers, showcasing advanced technologies like the ARTIS icono ceiling Xpand and the Biograph Vision Quadra PET/CT, aimed at improving diagnostic precision and treatment outcomes [6][7] - **Novartis**: Presented nearly 20 innovative products, including the oral complement factor B inhibitor, Iptacopan, and the radioligand therapy drug, Pluvicto, which received approval for prostate cancer indications [10][12] - **Fosun Pharma**: Introduced the Marie upright particle therapy system, a revolutionary cancer treatment technology, along with advanced non-invasive treatment systems for neurological conditions [12][14] - **Boston Scientific**: Showcased over 80 products in the minimally invasive intervention field, including the Orbera365 gastric balloon system and the Intera3000 hepatic artery infusion pump, with several products making their debut [15][17] - **Novo Nordisk**: Highlighted advancements in diabetes and obesity treatments, including the oral GLP-1 receptor agonist, Rybelsus, and the weekly insulin formulation, IcoSema, which have significantly improved patient convenience [18][20]

在第八届中国国际进口博览会展馆内，体型颇大的"进博号"轮船模型颇为吸睛，透过模型的"舷窗"可以 看到多个首发医疗产品：全程无针暴露的静脉留置针，可以降低患者术后疼痛的疝修补补片…… 11月4日，中国证券报记者提前进入进博会展馆实探发现，医药、汽车等多个领域的最新"黑科技"产品 即将展出。本届进博会吸引了155个国家、地区和国际组织参与，4108家境外企业参展，整体展览面积 超过43万平方米，规模再创新高，多项具有代表性的首发新产品、新技术、新服务亮相，为全球"尖 货"进入中国市场搭建了"首秀场"。 首发首秀产品亮相 在"进博号"旁，碧迪医疗大中华区企业品牌公关及数智传播总监李莎向记者介绍了"舷窗"内的部分产 品：Ferghana防针刺伤型静脉留置针通过全程无针暴露的一体化设计，有效降低针刺伤风险，强化医护 人员职业安全；新款3DMax疝修补补片采用全球首创3D立体结构与解剖定位线，快速展开、无需固 定，提高手术效率并降低术后疼痛。 走到"进博号"的不远处，就可以看到复星医药带来的首展产品——Marie立式粒子治疗室内系统。复星 医药品牌与公众传播部总经理易锦媛表示，作为肿瘤治疗领域的革命性突破，这一产品摒弃了 ...

"Cybercab采用特斯拉视觉处理系统+端到端神经网络的自动驾驶方案，无需使用激光雷达等价格昂贵的 硬件设备，就可以实现无人驾驶，还配备了无线充电技术与机械臂自动清洁功能，为规模化落地做好了 充分准备。这款车计划在2026年第二季度启动量产。"特斯拉上海区总经理孙嘉泽说。 展品加速变商品 在不少受访企业看来，进博会为其开通了进入中国市场的高速路。 ● 本报记者 王舒嫄 连润 在第八届中国国际进口博览会展馆内，体型颇大的"进博号"轮船模型颇为吸睛，透过模型的"舷窗"可以 看到多个首发医疗产品：全程无针暴露的静脉留置针，可以降低患者术后疼痛的疝修补补片…… 11月4日，中国证券报记者提前进入进博会展馆实探发现，医药、汽车等多个领域的最新"黑科技"产品 即将展出。本届进博会吸引了155个国家、地区和国际组织参与，4108家境外企业参展，整体展览面积 超过43万平方米，规模再创新高，多项具有代表性的首发新产品、新技术、新服务亮相，为全球"尖 货"进入中国市场搭建了"首秀场"。 首发首秀产品亮相 在"进博号"旁，碧迪医疗大中华区企业品牌公关及数智传播总监李莎向记者介绍了"舷窗"内的部分产 品：Ferghana防针刺伤 ...

● 本报记者 王舒嫄 连润 在第八届中国国际进口博览会展馆内，体型颇大的"进博号"轮船模型颇为吸睛，透过模型的"舷窗"可以 看到多个首发医疗产品：全程无针暴露的静脉留置针，可以降低患者术后疼痛的疝修补补片…… 11月4日，中国证券报记者提前进入进博会展馆实探发现，医药、汽车等多个领域的最新"黑科技"产品 即将展出。本届进博会吸引了155个国家、地区和国际组织参与，4108家境外企业参展，整体展览面积 超过43万平方米，规模再创新高，多项具有代表性的首发新产品、新技术、新服务亮相，为全球"尖 货"进入中国市场搭建了"首秀场"。 首发首秀产品亮相 参展商变投资方 商务部副部长盛秋平此前表示，进博会是近距离观察中国高水平对外开放的"大舞台"，也是沉浸式感受 中国超大规模市场优势的"体验区"。 进博会不仅让外国企业、商品加速进入中国，更成功吸引了大批进博会参展商变身投资商。 在"进博号"旁，碧迪医疗大中华区企业品牌公关及数智传播总监李莎向记者介绍了"舷窗"内的部分产 品：Ferghana防针刺伤型静脉留置针通过全程无针暴露的一体化设计，有效降低针刺伤风险，强化医护 人员职业安全；新款3DMax疝修补补片采用全球首创3 ...

第八届中国国际进口博览会（下称"进博会"）将于11月5日至10日在上海举办。中国证券报记者11月4日 提前探访"四叶草"展馆时发现，在医疗器械及医药保健展区内，碧迪医疗展位上体型颇大的"进博号"轮 船模型引人注目，"舷窗"内摆放了多个全球首发、中国首发及限定首发新品。 Ferghana防针刺伤型静脉留置针通过全程无针暴露的一体化设计，可以有效降低针刺伤风险，强化医护 人员职业安全；新款3DMax疝修补补片采用全球首创3D立体结构与解剖定位线，可以快速展开、无需 固定，能提高手术效率并降低术后疼痛……碧迪医疗大中华区企业品牌公关及数智传播总监李莎向记者 介绍"进博号"上"载着"的产品。 包括碧迪医疗在内，本届进博会吸引了155个国家、地区和国际组织参与，4108家境外企业参展，整体 展览面积超过43万平方米，规模再创新高，多项代表性首发新产品、新技术、新服务在此发布。进博会 正为世界"尖货"进入中国市场搭建"首秀场"。 据尼尔森透露，虽然图蒂制药进入中国仅短短一年时间，但已有在中国投资建厂的计划。"中国的研发 技术好、生产质量优、供应链完善，制药企业需要大量技术型人才和友好的临床试验环境，我们希望在 中国有更完 ...